The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Rapidly progressive dementia
Open accessAbstract
In contrast with more common dementing conditions that typically develop over years, rapidly progressive dementias can develop subacutely over months, weeks, or even days and be quickly fatal. Because many rapidly progressive dementias are treatable, it is paramount to evaluate and diagnose these patients quickly. This review summarizes recent advances in the understanding of the major categories of RPD and outlines efficient approaches to the diagnosis of the various neurodegenerative, toxic‐metabolic, infectious, autoimmune, neoplastic, and other conditions that may progress rapidly. Ann Neurol 2008;64:97–108
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationParaneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492 · cited 1×
“For instance, anti-Hu and anti-CV2 antibodies are associated with small-cell lung cancer, anti-Ma2 with testicular cancer, and anti–N-methyl-D-aspartate receptor with ovarian teratomas.(66,67) Detection of these antibodies in the proper clinical context should prompt an aggressive investigation for the corresponding t…”
BackgroundHarrison's Principles of Internal Medicine
Freeman, D. L. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.286.8.971-a · Cited by 1,624
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Brown, P., Gibbs, C. J., Rodgers‐Johnson, P., Asher, D. M., Sulima, M. P., Bacote, A., Goldfarb, L. G., & Gajdusek, D. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350504 · Cited by 817
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Hirsch, H. H., & Steiger, J. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00770-9 · Cited by 662
Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H., & Harrington, M. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351303 · Cited by 660
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis
Glaser, C. A., Honarmand, S., Anderson, L. J., Schnurr, D. P., Forghani, B., Cossen, C. K., Schuster, F. L., Christie, L. J., & Tureen, J. H. (2006) · Clinical Infectious Diseases · doi:10.1086/509330 · Cited by 650
Cited by
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias
Vitali, P., Maccagnano, E., Caverzasi, E., Henry, R. G., Haman, A., Torres-Chae, C., Johnson, D. Y., Miller, B. L., & Geschwind, M. D. (2011) · Neurology · doi:10.1212/wnl.0b013e31821a4439 · Cited by 399
Self-citationSankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
Skillbäck, T., Rosén, C., Asztely, F., Mattsson, N., Blennow, K., & Zetterberg, H. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6455 · Cited by 207
Geschwind, M. D. (2016) · Continuum · doi:10.1212/con.0000000000000319 · Cited by 131
Self-citationBernstein, A., Rogers, K. M., Possin, K. L., Steele, N. Z. R., Ritchie, C. S., Kramer, J. H., Geschwind, M., Higgins, J. J., Wohlgemuth, J., Pesano, R., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4603-2 · Cited by 120
Self-citationLaforce, R., & Rabinovici, G. D. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt93 · Cited by 79
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0466-z · Cited by 60
Goodman, D. W., Mitchell, S., Rhodewalt, L., & Surman, C. B. H. (2016) · Drugs & Aging · doi:10.1007/s40266-015-0327-0 · Cited by 59
Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease
Kim, C., Haldiman, T., Kang, S.-G., Hromadkova, L., Han, Z. Z., Chen, W., Lissemore, F., Lerner, A., de Silva, R., Cohen, M. L., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg0253 · Cited by 55
In vivo [ 18 F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease
Day, G. S., Gordon, B. A., Perrin, R. J., Cairns, N. J., Beaumont, H., Schwetye, K., Ferguson, C., Sinha, N., Bucelli, R., Musiek, E. S., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005064 · Cited by 26
Metadata
- Authors
- Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 64
- Issue
- 1
- Pages
- 97-108
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2000602998
- Cited by
- 323
- References
- 131
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.